442 related articles for article (PubMed ID: 20077322)
1. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
[No Abstract] [Full Text] [Related]
2. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
[TBL] [Abstract][Full Text] [Related]
3. Why academic medical centers should ban drug company gifts to individuals.
Strong C
Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
[No Abstract] [Full Text] [Related]
4. The pitfalls of misreading: what does "industry funding of medical education" actually say?
Spielman B
Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
[No Abstract] [Full Text] [Related]
5. Contact with pharmaceutical representatives: where does prudence lead?
Appelbaum PS
Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
[No Abstract] [Full Text] [Related]
6. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
7. Drug detailers, professionalism, and prudence.
Brody H
Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
[No Abstract] [Full Text] [Related]
8. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
9. The AAMC exhibits the behavior it condemns.
Stossel TP
Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
[No Abstract] [Full Text] [Related]
10. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
11. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
12. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
Steinman MA; Schillinger D
Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
[No Abstract] [Full Text] [Related]
13. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
Mehta RS
Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
[No Abstract] [Full Text] [Related]
14. Doctors and the drug industry: reader feedback.
Warrier R; Houghton B
Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
[No Abstract] [Full Text] [Related]
15. Medicine and the pharmaceutical industry: a call to action.
Stiles MM; Barrett B
Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
[No Abstract] [Full Text] [Related]
16. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
[No Abstract] [Full Text] [Related]
17. Banning pens and pads misses the main point.
Terry SF; Burke W
Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
[No Abstract] [Full Text] [Related]
18. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
Moynihan R
BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
[TBL] [Abstract][Full Text] [Related]
19. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
20. Drug industry is told to stop gifts to doctors.
Pear R
N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
